000 01539 a2200397 4500
005 20250515202848.0
264 0 _c20100927
008 201009s 0 0 eng d
022 _a1708-8267
024 7 _a10.231/JIM.0b013e3181ccc20c
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBolignano, Davide
245 0 0 _aNeutrophil gelatinase-associated lipocalin levels in patients with crohn disease undergoing treatment with infliximab.
_h[electronic resource]
260 _bJournal of investigative medicine : the official publication of the American Federation for Clinical Research
_cMar 2010
300 _a569-71 p.
_bdigital
500 _aPublication Type: Clinical Trial; Journal Article
650 0 4 _aAcute-Phase Proteins
_xurine
650 0 4 _aAntibodies, Monoclonal
_xadministration & dosage
650 0 4 _aCase-Control Studies
650 0 4 _aCrohn Disease
_xdrug therapy
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aInfliximab
650 0 4 _aLipocalin-2
650 0 4 _aLipocalins
_xurine
650 0 4 _aMale
650 0 4 _aProto-Oncogene Proteins
_xurine
650 0 4 _aYoung Adult
700 1 _aDella Torre, Anna
700 1 _aLacquaniti, Antonio
700 1 _aCostantino, Giuseppe
700 1 _aFries, Walter
700 1 _aBuemi, Michele
773 0 _tJournal of investigative medicine : the official publication of the American Federation for Clinical Research
_gvol. 58
_gno. 3
_gp. 569-71
856 4 0 _uhttps://doi.org/10.231/JIM.0b013e3181ccc20c
_zAvailable from publisher's website
999 _c19440676
_d19440676